Obstetrics & GynaecologyDr. Archit PanditGynaecologic Oncology

Director, Surgical Oncology, Fortis Escorts, Okhla, New Delhi

Part 7 of 11 in Advanced Treatments in Gynaec Oncology

Diagnostic Advances in Gynaecologic Oncology: Genetic Testing, PET-CT and AI

Beyond the routine transvaginal ultrasound and PET-MRI scan, Dr. Pandit's masterclass covers a set of newer diagnostic tools now used to stage disease, identify genetic risk, and guide treatment choice.

PET-CT for staging

PET-CT scans the entire body and shows whether a cancer has spread beyond its original site, a step beyond what transvaginal sonography or PET-MRI alone can establish.

Genetic testing for cancer risk

BRCA testing identifies who is at elevated risk of developing certain cancers before a diagnosis exists. It gained wide public awareness after Angelina Jolie's decision to undergo it. HRD testing and MSI testing add further detail, identifying features of a tumour that determine which treatments, including targeted therapy and immunotherapy, are likely to work.

Next-generation sequencing

Next-generation sequencing, which reads a tumour's genetic mutations directly, is now performed at five to seven centres in India. The result determines whether a patient is a candidate for a specific targeted drug rather than standard chemotherapy.

AI has entered routine diagnosis

Artificial intelligence is now built into pap smear analysis, radiology reads and CT scan interpretation at Dr. Pandit's hospital, intended to catch disease earlier and reduce the human error that comes with reading large volumes of scans and slides manually.

This guide is based on a live Jivo Masterclass — Dr. Archit Pandit taught doctors across Africa on June 22, 2025.

FROM THE LIVE Q&A

DR

Dr. Sunday

What can be done to improve overall healthcare delivery to doctors and patients across Africa?

AP

Dr. Archit Pandit

Varun, the session host, said this reflects the underlying model of the collaboration: connecting Indian specialists using current-day technology and treatment processes with doctors across Africa to help achieve better medical outcomes, and offered to continue the conversation with Dr. Sunday directly after the session.

See all 6 questions from this masterclass →

Book a Consultation with Dr. Archit Pandit

Book on WhatsApp

Or message us on WhatsApp: +91 98182 98669

Frequently Asked Questions

What is the cost range for laparoscopic surgeries for gynaecologic oncology cases, and does the hospital offer chemoradiotherapy, IMRT and VMAT?

Dr. Pandit said laparoscopic cancer surgery, including radical hysterectomy and hysterectomy, typically costs between $5,000 and $5,500, while procedures for endometriosis such as myomectomy range from $5,000 to $6,500. Fortis offers the full range of radiation oncology, including 3D-CRT, IMRT, IGRT, 3D-ARC, CyberKnife and tomotherapy, as well as brachytherapy, and has access to targeted therapy, immunotherapy and, at one centre in India, CAR-T cell therapy.

What is the utility of high-intensity focused ultrasound (HIFU) therapy for gynaecologic malignancies, is it available at your institution, and what does it cost?

Dr. Pandit said focused high-frequency ultrasound therapy is generally used for small fibroids rather than malignancy, which is his own area of focus, but confirmed Fortis does perform it, at a cost of $4,500 to $6,500.

What advancements has Fortis made for African patients with gynaecologic malignancies, and what are the most recent and frequent surgical treatments and their estimated costs?

Dr. Pandit said no treatment is specific to African patients as such, but pointed to cancer vaccination, for cervical, genital, vaginal and vulval cancers, as an area worth spreading in Africa. On surgery, he named HIPEC as the most significant advancement, now used for ovarian cancer along with peritoneal, appendiceal, colon, rectal and some stomach cancers, transforming outcomes over the last 10 to 15 years for patients previously diagnosed too late for treatment. He also pointed to robotic and laparoscopic surgery for retroperitoneal lymph node dissection, endometriosis and radical hysterectomy, and to sentinel lymph node dissection, which avoids removing the full set of pelvic lymph nodes. Surgical costs range from $5,000 to $7,000, and HIPEC surgery costs $11,000 to $12,000.

Since HIPEC is used from stage three onward, is it possible to use HIPEC or another technology to operate on a stage two cervical cancer patient?

Dr. Pandit said no, HIPEC is not used for cervical cancer at all. It is limited to six cancers: peritoneal, appendiceal, ovarian, colon, rectal and some stomach cancers, and of the gynaecologic cancers, only ovarian and endometrial cancer qualify. Cervical cancer is treated with surgery in its early stages, and with chemotherapy, radiation and sometimes immunotherapy from stage 2B onward.

How can general practitioners from Africa access surgical training courses at Fortis?

After clarifying the question was about medicine-side doctors rather than surgeons, Dr. Pandit said they can join as observers, since hands-on training in India is reserved for foreign doctors who are themselves surgeons or gynaecologists. Observers get an overview of cancer care spanning preventive health checkups, medical oncology and surgical oncology, and can join the hospital's tumour board, the round-table meeting where the full team reviews each case against the current world literature.

Need Expert Medical Guidance?

Connect with leading specialists through the Jivo Healthcare network for personalized advice.

Get Expert Opinion